These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8124254)

  • 1. Treatment of GVHD--TNF-antibodies and related antagonists.
    Holler E; Kolb HJ; Wilmanns W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S29-31. PubMed ID: 8124254
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
    Holler E; Kolb HJ; Hintermeier-Knabe R; Mittermüller J; Thierfelder S; Kaul M; Wilmanns W
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1234-6. PubMed ID: 8442099
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
    Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
    Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice.
    Vallera DA; Taylor PA; Vannice JL; Panoskaltsis-Mortari A; Blazar BR
    Transplantation; 1995 Dec; 60(11):1371-4. PubMed ID: 8525541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel strategies for the treatment and diagnosis of graft-versus-host-disease.
    Ferrara JL
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):91-7. PubMed ID: 17336259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy with anti-TNF antibodies in patients with Crohn disease].
    Eigler A; Endres S
    Z Gastroenterol; 1997 Sep; 35(9):899-901. PubMed ID: 9432823
    [No Abstract]   [Full Text] [Related]  

  • 7. [TNF alfa modulators in the treatment of rheumatoid arthritis].
    Kochbati S; Boussema F; Ben Miled M; Ktari S; Daoud L; Ben Rhouma S; Ben Amor G; Chérif O; Rokbani L
    Tunis Med; 2004 Oct; 82(10):893-904. PubMed ID: 15686185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-TNF antibodies in the treatment of intestinal inflammatory disease].
    Hinojosa J
    Gastroenterol Hepatol; 2000 May; 23(5):250-7. PubMed ID: 10902280
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.
    Brown SJ; Abreu MT
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):160-8. PubMed ID: 15782540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies.
    Tsimberidou AM; Giles FJ
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):277-86. PubMed ID: 12113051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor and inflammatory bowel disease.
    Armstrong AM; Gardiner KR; Kirk SJ; Halliday MI; Rowlands BJ
    Br J Surg; 1997 Aug; 84(8):1051-8. PubMed ID: 9278640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Crohn's disease with anti-TNF alpha].
    Lémann M
    Rev Prat; 1998 May; 48(10):1049-50. PubMed ID: 9781146
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective monitoring of tumor necrosis factor alpha and interferon gamma to predict the onset of acute and chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Ritchie D; Seconi J; Wood C; Walton J; Watt V
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):706-12. PubMed ID: 16125641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategy for post-transfusion graft-vs.-host disease.
    Saigo K; Ryo R
    Int J Hematol; 1999 Apr; 69(3):147-51. PubMed ID: 10222651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD.
    El-Hayek JM; Rogers TE; Brown GR
    J Leukoc Biol; 2005 Oct; 78(4):1001-7. PubMed ID: 16081594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis.
    Stokes DG; Kremer JM
    Semin Arthritis Rheum; 2003 Aug; 33(1):1-18. PubMed ID: 12920692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human scFv fragment against TNF-alpha from de novo design method.
    Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
    Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease.
    Facon T; Jouet JP; Noel-Walter MP; Bloget F; Bauters F; Janin A
    Bone Marrow Transplant; 1997 Sep; 20(6):511-5. PubMed ID: 9313887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.